Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Kit Type
1.1.2. Device Type
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Kit type outlook
2.2.2. Device type outlook
2.2.3. Application outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Paper Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Paper Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Paper Diagnostics Market: Kit Type Estimates & Trend Analysis
4.1. Paper Diagnostics Market: Key Takeaways
4.2. Paper Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Lateral Flow Assays
4.3.1. Lateral flow assays market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Dipsticks
4.4.1. Dipsticks market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Paper Based Microfluidics
4.5.1. Paper based microfluidics market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Paper Diagnostics Market: Device Type Estimates & Trend Analysis
5.1. Paper Diagnostics Market: Key Takeaways
5.2. Paper Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Diagnostic Devices
5.3.1. Diagnostics devices market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Monitoring Devices
5.4.1. Monitoring devices market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Paper Diagnostics Market: Application Estimates & Trend Analysis
6.1. Paper Diagnostics Market: Key Takeaways
6.2. Paper Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Clinical Diagnostics
6.3.1. Clinical Diagnostics market estimates and forecasts, 2018 to 2030 (USD Billion)
6.3.2. Cancer
6.3.2.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Billion)
6.3.3. Infectious diseases
6.3.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
6.3.4. Liver disorders
6.3.4.1. Liver disorders market estimates and forecasts, 2018 to 2030 (USD Billion)
6.3.5. Other
6.3.5.1. Other market estimates and forecasts, 2018 to 2030 (USD Billion)
6.4. Food Quality Testing
6.4.1. Food quality testing market estimates and forecasts, 2018 to 2030 (USD Billion)
6.5. Environmental Monitoring
6.5.1. Environmental monitoring market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 7. Paper Diagnostics Market: End-use Estimates & Trend Analysis
7.1. Paper Diagnostics Market: Key Takeaways
7.2. Paper Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Home Healthcare
7.3.1. Home Healthcare market estimates and forecasts, 2018 to 2030 (USD Billion)
7.4. Assisted Living Healthcare Facilities
7.4.1. Assisted Living Healthcare Facilities market estimates and forecasts, 2018 to 2030 (USD Billion)
7.5. Hospitals and Clinics
7.5.1. Hospitals and clinics market estimates and forecasts, 2018 to 2030 (USD Billion)
7.6. Others
7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 8. Paper Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Paper Diagnostics Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.6. Denmark
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.7. Sweden
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.4.8. Norway
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.7.2. Saudi Arabia
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. Arkray, Inc.
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Acon Laboratories, Inc.
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Abbott (Alere Inc.)
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Bio-Rad Laboratories, Inc.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Gvs S.P.A.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Siemens Healthcare Gmbh
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Diagnostics For All, Inc.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Ffei Life Science (Biognostix)
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Navigene
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Micro Essential Laboratory Inc
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. Kenosha Tapes
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer